Scinai sets ADS change equal to 1-for-4 reverse split
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Scinai Immunotherapeutics Ltd. (SCNI) announced that, effective November 19, 2026, its ADS ratio will change from one ADS representing 40,000 ordinary shares to one ADS representing 160,000 ordinary shares. For ADS holders, the change has the same effect as a one-for-four reverse split. ADSs are expected to begin trading on an adjusted basis at the opening of trading that day on the Nasdaq Capital Market under the symbol SCNI.
The company says the change is intended to increase the per-ADS trading price and regain compliance with Nasdaq’s $1.00 minimum bid price requirement; there is no assurance it will regain or maintain compliance. Holders need take no action. Fractional entitlements will be aggregated, and the depositary bank will attempt to sell them and distribute the net cash proceeds to applicable holders.
Key Figures
Key Terms
one-for-four reverse split technical
Nasdaq Listing Rule 5550(a)(2) regulatory
minimum bid price regulatory
fractional entitlements technical
Stock Split
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the SCNI ADS ratio change?
AI-generated analysis. How Rhea-AI works. Not financial advice.